Structure-Based Design of a Novel Covalent 4-(1-Methylindol-3-yl)pyrimidin-2-amine Series Targeting FGFR2 Resistance MutationsRobert L. Hudkins, Daniel C. Bensen, Isaac Hoffman et al.|Journal of Medicinal Chemistry|2026Cited by 0